Viral amyloids: New opportunities for antiviral therapeutic strategies. 2023

Frank Gondelaud, and Pierre-Yves Lozach, and Sonia Longhi
Laboratoire Architecture et Fonction des Macromolécules Biologiques (AFMB), UMR 7257, Aix Marseille University and Centre National de la Recherche Scientifique (CNRS), 163 Avenue de Luminy, Case 932, 13288 Marseille, France.

Amyloidoses are an array of diseases associated with the aggregation of proteins into fibrils. While it was previously thought that amyloid fibril-forming proteins are exclusively host-cell encoded, recent studies have revealed that pathogenic viruses can form amyloid-like fibrils too. Intriguingly, viral amyloids are often composed of virulence factors, known for their contribution to cell death and disease progression. In this review, we survey the literature about viral proteins capable of forming amyloid-like fibrils. The molecular and cellular mechanisms underlying the formation of viral amyloid-like aggregates are explored. In addition, we discuss the functional implications for viral amplification and the complex interplay between viral amyloids, biological functions, virulence, and virus-induced pathologies.

UI MeSH Term Description Entries
D000682 Amyloid A fibrous protein complex that consists of proteins folded into a specific cross beta-pleated sheet structure. This fibrillar structure has been found as an alternative folding pattern for a variety of functional proteins. Deposits of amyloid in the form of AMYLOID PLAQUES are associated with a variety of degenerative diseases. The amyloid structure has also been found in a number of functional proteins that are unrelated to disease. Amyloid Fibril,Amyloid Fibrils,Amyloid Substance,Fibril, Amyloid,Fibrils, Amyloid,Substance, Amyloid
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D058227 Amyloidogenic Proteins Proteins that form the core of amyloid fibrils. For example, the core of amyloid A is formed from amyloid A protein, also known as serum amyloid A protein or SAA protein. Amyloid Protein,Amyloidogenic Protein,Amyloid Proteins,Protein, Amyloid,Protein, Amyloidogenic,Proteins, Amyloid,Proteins, Amyloidogenic
D037521 Virulence Factors Those components of an organism that determine its capacity to cause disease but are not required for its viability per se. Two classes have been characterized: TOXINS, BIOLOGICAL and surface adhesion molecules that effect the ability of the microorganism to invade and colonize a host. (From Davis et al., Microbiology, 4th ed. p486) Pathogenicity Factor,Pathogenicity Factors,Virulence Factor,Factor, Pathogenicity,Factor, Virulence,Factors, Pathogenicity,Factors, Virulence

Related Publications

Frank Gondelaud, and Pierre-Yves Lozach, and Sonia Longhi
January 2016, Molecular & cellular oncology,
Frank Gondelaud, and Pierre-Yves Lozach, and Sonia Longhi
November 2023, Viruses,
Frank Gondelaud, and Pierre-Yves Lozach, and Sonia Longhi
October 2014, Cellular and molecular life sciences : CMLS,
Frank Gondelaud, and Pierre-Yves Lozach, and Sonia Longhi
June 2020, Nature communications,
Frank Gondelaud, and Pierre-Yves Lozach, and Sonia Longhi
June 2021, Molecular and cellular biochemistry,
Frank Gondelaud, and Pierre-Yves Lozach, and Sonia Longhi
October 2021, Current opinion in chemical biology,
Frank Gondelaud, and Pierre-Yves Lozach, and Sonia Longhi
April 2000, Antimicrobial agents and chemotherapy,
Frank Gondelaud, and Pierre-Yves Lozach, and Sonia Longhi
January 2013, Current hepatitis reports,
Frank Gondelaud, and Pierre-Yves Lozach, and Sonia Longhi
January 2023, Archiv der Pharmazie,
Frank Gondelaud, and Pierre-Yves Lozach, and Sonia Longhi
June 2023, Current opinion in biotechnology,
Copied contents to your clipboard!